Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H23NO2 |
Molecular Weight | 261.3593 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CO[C@@](CC)(O1)C2=CC=CC=C2)[C@]3([H])CCCCN3
InChI
InChIKey=INOYCBNLWYEPSB-XHSDSOJGSA-N
InChI=1S/C16H23NO2/c1-2-16(13-8-4-3-5-9-13)18-12-15(19-16)14-10-6-7-11-17-14/h3-5,8-9,14-15,17H,2,6-7,10-12H2,1H3/t14-,15+,16-/m0/s1
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16169732 |
19.8 null [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of intravenous anesthetics on continuous avoidance behavior in the rat. | 1976 Feb |
|
Clinical investigation of a new intravenous anesthetic--etoxadrol hydrochloride (CL-1848; U-37862A). | 1976 May-Jun |
|
Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys. | 1982 Jan |
|
Synthesis, absolute configuration, and molecular modeling study of etoxadrol, a potent phencyclidine-like agonist. | 1988 Dec |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5921
0.75 mg/kg
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID00865419
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY | |||
|
30163-01-0
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY | |||
|
14208380
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY | |||
|
RO44G6QT80
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD